Dashboard
Portfolios
Watchlist
Community
Discover
Screener
GI
Giuca
Community Contributor
Followers
3
Total number of followers
Comments
0
Total number of comments
Member Since
2024
Date joined
Corcept Therapeutics
GI
Giuca
Community Contributor
Corcept and its fair value according my DCF valuation
Ottima azienda solida finanziariamente senza debiti a lungo e breve termine. Il FcF tende a diminuire nel tempo mentre aumentano i compensi per i vari membri del board che hanno uno skill in the game moderato.
View narrative
US$63.53
FV
9.3% undervalued
intrinsic discount
19.41%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
6 months ago
author updated this narrative